Physicians and other health care providers are finding molecular diagnostics to be a useful part of their practice, and the number of genetic tests available continues to grow at a rapid pace.

Myriad Genetics, Inc. MYGN recently entered into a research partnership with National Cancer Center Hospital East ("NCCHE") in Japan to evaluate the prognostic and predictive value of molecular ...

From left, this picture shows Eric Edsinger, Daniel Rokhsar, Head of the Molecular Genetics Unit and Oleg Simakov, co-first-author. Disclaimer: AAAS and EurekAlert! are not responsible for the ...

Physician Practice Variability in the Use of Extended-Fraction Radiation Therapy for Bone Metastases: Are We Choosing Wisely? Using the aggregated results of a questionnaire developed and distributed ...

At-home genetic testing can offer insight into everything from ancestry and physical traits to risk of diseases like Alzheimer’s, Parkinson’s and cancer. But how accurate are these results and what ...

In the article that accompanies this editorial, Smith et al 9 examine the association between availability of molecular testing before treatment decisions and outcomes such as time to next treatment ...

Dr Haumschild aligns payer considerations with molecular testing and biomarker application for treatment of patients with mCRC. Ryan Haumschild, PharmD, MS, MBA: There are considerations for molecular ...